Current application of high flow oxygen nasal cannula in acute hypoxemic respiratory failure in the emergency department


Submitted: 5 September 2017
Accepted: 11 January 2018
Published: 26 March 2018
Abstract Views: 1210
PDF: 683
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

High flow oxygen with nasal cannula (HFONC) is a relatively new mode of oxygen delivery. Advantages of HFONC versus conventional oxygen therapy (COT) encompass carbon dioxide washout, generation of a slight positive end-expiratory pressure and maintenance of humidified gas flow through airways. These features are mostly shared with non-invasive mechanical ventilation (NIMV), although with lack of a clearly comparable efficacy. In the last few years, HFONC has gained interest as a third alternative to COT and NIMV in the management of acute hypoxemic respiratory failure in the critically ill patient, both in intensive care units and emergency departments. The aim of this article is to review indications, effects and existing evidence on HFONC, COT and NIMV in the setting of acute hypoxemic respiratory failure.

Bottani, G., Centurioni, F., Veronese, G., Vincenti, F., Forni, E., & Bellone, A. (2018). Current application of high flow oxygen nasal cannula in acute hypoxemic respiratory failure in the emergency department. Emergency Care Journal, 13(2). https://doi.org/10.4081/ecj.2017.7036

Downloads

Download data is not yet available.

Citations